Basel Medical Group (NASDAQ:BMGL) Releases Quarterly Earnings Results

Posted by Brian Himes on Jun 26th, 2026

Basel Medical Group (NASDAQ:BMGL – Get Free Report) posted its quarterly earnings data on Friday. The company reported $0.00 EPS for the quarter, FiscalAI reports. The firm had revenue of $3.21 million for the quarter.

Basel Medical Group Stock Down 4.6%

NASDAQ BMGL opened at $6.71 on Friday. Basel Medical Group has a twelve month low of $4.60 and a twelve month high of $54.60. The business has a 50-day moving average price of $7.45 and a 200-day moving average price of $7.77.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Citadel Advisors LLC bought a new position in Basel Medical Group in the 3rd quarter worth approximately $169,000. Virtu Financial LLC raised its position in shares of Basel Medical Group by 108.8% during the third quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock valued at $61,000 after buying an additional 17,608 shares during the last quarter. Finally, Marex Group plc purchased a new position in shares of Basel Medical Group in the second quarter worth $25,000.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, June 15th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, Basel Medical Group currently has a consensus rating of “Sell”.

Check Out Our Latest Analysis on BMGL

Basel Medical Group Company Profile

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.